Literature DB >> 12167440

Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998.

María Teresa Canto1, Susan S Devesa.   

Abstract

To identify subgroups of oral cavity and pharynx (OCP) cancers that may be etiologically distinct, we evaluated age-adjusted incidence rates by histologic type, anatomical site, race, and sex using cases diagnosed during 1975-1998 in nine US Surveillance, Epidemiology, and End Results (SEER) program registries. Male/female rate ratios were about one for adenocarcinoma (AC), three or more for squamous cell carcinoma (SCC), and undetermined for Kaposi's sarcoma (KS). Among males, black/white rate ratios exceeded two for cancers of the palate, tonsil, oropharynx, and pyriform sinus, and were less than one only for lip and salivary gland cancers. Among females, rates by race were similar for all oral sites except lip, but rates for each of the pharynx subsites were higher among blacks. Findings suggest that OCP cancers may be separated into SCC of the lip, SCC of the oral cavity, SCC of the pharynx, AC, and KS.

Entities:  

Mesh:

Year:  2002        PMID: 12167440     DOI: 10.1016/s1368-8375(01)00109-9

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  34 in total

1.  Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Paraskevi Alexandrou; Efstratios Patsouris; Xavier Sastre-Garau
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

2.  Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.

Authors:  Flávio J Pimenta; Dawidson A Gomes; Paolla F Perdigão; Alvimar A Barbosa; Marco A Romano-Silva; Marcus V Gomez; C Marcelo Aldaz; Luiz De Marco; Ricardo S Gomez
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

3.  Trends in incidence of oral and pharyngeal carcinoma in Florida: 1981-2008.

Authors:  Susan P McGorray; Yi Guo; Henrietta Logan
Journal:  J Public Health Dent       Date:  2011-09-19       Impact factor: 1.821

Review 4.  Robotic surgery for oropharynx cancer: promise, challenges, and future directions.

Authors:  John R de Almeida; Eric M Genden
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

5.  Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans.

Authors:  Douglas E Morse; A Ross Kerr
Journal:  J Am Dent Assoc       Date:  2006-02       Impact factor: 3.634

6.  Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.

Authors:  Ru Jiang; Oleksandr Ekshyyan; Tara Moore-Medlin; Xiaohua Rong; Sean Nathan; Xin Gu; Fleurette Abreo; Eben L Rosenthal; Mingxia Shi; Joseph T Guidry; Rona S Scott; Lindsey M Hutt-Fletcher; Cherie-Ann O Nathan
Journal:  J Oral Pathol Med       Date:  2014-07-18       Impact factor: 4.253

7.  Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Authors:  Oleksandr Ekshyyan; Youhua Rong; Xiaohua Rong; Kavita M Pattani; Fleurette Abreo; Gloria Caldito; John Kai Siung Chang; Federico Ampil; Jonathan Glass; Cherie-Ann O Nathan
Journal:  Mol Cancer Ther       Date:  2009-07-22       Impact factor: 6.261

Review 8.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

9.  Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years.

Authors:  Astrid L D Kruse; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2009-07-20

10.  Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.

Authors:  Jeffrey S Tobias; Kathryn Monson; Nirmal Gupta; Hugh Macdougall; John Glaholm; Iain Hutchison; Latha Kadalayil; Allan Hackshaw
Journal:  Lancet Oncol       Date:  2009-10-29       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.